Residual symptoms in depression;Síntomas residuales en la depresión

Actas Espanolas de Psiquiatria

Volumn 37, Issue 2, 2009, Pages 101-105

  Garcia, C Iglesias ^a   Villa, M J Alonso ^b  

^a HOSPITAL VALLE DEL NALÓN   (Spain)

^b Principado de Asturias   (Spain)

Author keywords

Antidepressants; Depression; Prognosis; Residual symptom

Indexed keywords

EID: 84888617485     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, re-lapse, and recurrence. Arch Gen Psychiatry 1991;48(9):851-5.
2. American Psychiatric Association. DSM-IV Manual Diagnostico y Estadistico de los Trastornos Mentales. Barcelona: Masson S.A.; 1995.
3. Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Wor- Thington JJ 3rd, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60(4): 221-5.
4. Zimmerman M, Posternak MA, Chelminski I. Heterogeneity among depressed outpatients considered to be in remission. Comprehens Psychiatry 2007;48(2):113-7.
5. Judd LL, Akiskal HS, Paulus MP. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 1997;45(1-2):5-17.
6. Cornwall PL, Scott J. Partial remission in depressive disorders. Acta Psychiatr Scand 1997;95(4):265-71.
7. Zimmerman M, McGlinchey JB, Posternak MA, Friedman M, At- Tiullah N, Boerescu D. How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry 2006;163(1):148-50.
8. Kupfer DJ, Spiker DG. Refractory depression: prediction of non-response by clinical indicators. J Clin Psychiatry 1981;42(8):307-12.
9. McEwan GW, Remick RA. Treatment resistant depression: A clinical perspective. Can J Psychiatry 1989;34(5):477-8.
10. Brodaty H, Harris L, Peters K, Wilhelm K, Hickie I, Boyce P, et al. Prognosis of depression in the elderly. A comparison with younger patients. Br J Psychiatry 1993;163:589-96.
11. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: An important outcome in depression. Psychol Med 1995;25:1171-80.
12. Van Londen L, Molenaar RP, Goekoop JG, Zwinderman AH, Ro- oijmans HG. Three- To 5-year prospective follow-up of outcome in major depression. Psychol Med 1998;28(3):731-5.
13. Ezquiaga E, Garcia A, Bravo F, Pallares T. Factors associated with outcome in major depression: A 6-month prospective study. Soc Psychiatry Psychiatr Epidemiol 1998;33(11):552-7.
14. Mojtabai R. Residual symptoms and impairment in major depression in the community. Am J Psychiatry 2001;158(10):1645-51.
15. Mclntyre RS, Konarski JZ, Soczynska JK, Kennedy SH. Residual anxiety symptoms in depressed primary care patients. J Psychiatr Pract 2007;13(2):125-8.
16. Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P. Long- Term social functioning after depression treated by psychiatrists: A review. Bipolar Disord 2007;9(1-2):25-37.
17. Weiland-Fiedler P, Erickson K, Waldeck T, Luckenbaugh DA, Pike D, Bonne O, et al. Evidence for continuing neuropsychological impairments in depression. J Affect Disord 2004;15; 82(2):253-8.
18. Fava GA, Fabbri S, Sonino N. Residual symptoms in depression: An emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry 2002;26(6): 1019-27.
19. Frasch K, Bretschneider S, Bullacher C, Hess R, Wittek R, Neumann NU. Do cognitive deficits in depressive disorders remit? Psychiatrische Praxis 2000;27(6):291-5.
20. Krakow BJ. Physiologic sleep disorders among treatment-res- ponsive depressed patients with residual cognitive and physical symptoms. J Clin Psychiatry 2007;68(9):1444-5.
21. Fava M. Pharmacological approaches to the treatment of residual symptoms. J Psychopharmacol 2006;20(Suppl. 3):29-34.
22. Hybels CF, Steffens DC, McQuoid DR, Rama Krishnan KR. Residual symptoms in older patients treated for major depression. Int J Geriatr Psychiatry 2005;20(12):1196-202.
23. Vieta E, Sanchez-Moreno J, Lahuerta J, Zaragoza S. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. J Affect Disord 2007;14.
24. Dombrovski AY, Mulsant BH, Houck PR, Mazumdar S, Lenze EJ, Andreescu C, et al. Residual symptoms and recurrence during maintenance treatment of late-life depression. J Affect Disord 2007;103(1-3):77-82.
25. Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Ga- brielle M, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000;57(3):285-90.
26. Portella MJ, Marcos T, Rami L, Navarro V, Gasto C, Salamero M. Residual cognitive impairment in late-life depression after a 12- month period follow-up. Int J Geriatr Psychiatry 2003; 18(7):571-6.
27. Paykel ES. Remission and residual symptomatology in major depression. Psychopathology 1998;31(1):5-14.
28. Abrams RC, Alexopoulos GS, Spielman LA, Klausner E, Kakuma T. Personality disorder symptoms predict declines in global functioning and quality of life in elderly depressed patients. Am J Geriatr Psychiatry 2001;9(1):67-71.
29. Morse JQ, Pilkonis PA, Houck PR, Frank E, Reynolds CF, 3rd. Impact of cluster C personality disorders on outcomes of acute and maintenance treatment in late-life depression. Am J Geriatr Psychiatry 2005;13(9):808-14.
30. Reynolds CF, 3rd, Perel JM, Frank E, Comes C, Miller MD, Houck PR, et al. Three-year outcomes of maintenance nortriptyline treatment in late-life depression: A study of two fixed plasma levels. Am J Psychiatry 1999;156(8):1177-81.
31. Tamayo JM, Rovner J, Munoz R. [The importance of detection and treatment of somatic symptoms in Latin American patients with major depression]. Rev Bras Psiquiatr 2007;29(2):182-7.
32. Oslin DW, Datto CJ, Kalian MJ, Katz IR, Edell WS, TenHave T. Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc 2002;50(5):823-8.
33. Awata S, Ito H, Konno M, Ono S, Kawashima R, Fukuda H, et al. Regional cerebral blood flow abnormalities in late-life depression: relation to refractoriness and chronification. Psychiatry Clin Neurosci 1998;52(1):97-105.
34. Duval F, Mokrani MC, Ortiz JA, Schulz P, Champeval C. Ma- cher JP. Neuroendocrine predictors of the evolution of depression. Dialog Clin Neurosci 2005;7(3):273-82.
35. Lam RW. High-quality remission: potential benefits of the me- latonergic approach for patients with major depressive disorder. Int Clin Psychopharmacol 2007;22 (Suppl. 2):S21-5.
36. Nelson JC, Portera L, Leon AC. Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine. J Clin Psychiatry 2005;66(11):1409-14.
37. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998;55(8):694-700.
38. Faravelli C, Ambonetti A, Pallanti S, Pazzagli A. Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 1986;143(7) :888-91.
39. Georgotas A, McCue RE, Cooper TB, Nagachandran N, Chang I. How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate. Arch Gen Psychiatry 1988;45(10):929-32.
40. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998;50(2-3):97-108.
41. Paykel ES. Achieving gains beyond response. Acta Psychiatr Scand 2002, (415):12-7.
42. Thase ME, Simons AD, McGeary J, Cahalane JF, Hughes C, Harden T, et al. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 1992;149(8):1046-52.
43. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992;49(10):761-8.
44. Guo Y, Kuroki T, Koizumi S. Abnormal illness behavior of patients with functional somatic symptoms: relation to psychiatric disorders. Gen Hosp Psychiatry 2001;23(4):223-9.
45. Chaturvedi SK, Bhandari S. Somatisation and illness behaviour. J Psychosom Res 1989;33(2):147-53.
46. Pilowsky I. Abnormal illness behaviour. Br J Med Psychol 1969;42(4):347-51.
47. Simon GE, Khandker RK, Ichikawa L, Operskalski BH. Recovery from depression predicts lower health services costs. J Clin Psychiatry 2006;67(8):1226-31.
48. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Char- ney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000;157(1):115-8.
49. Sheline Yl, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003;160(8):1516-8.
50. Bremner JD. Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectr 2002;7(2):129- 30, 35-9.
51. Frodl T, Meisenzahl EM, Zetzsche T, Hohne T, Banac S, Schorr C, et al. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 2004;65(4):492-9.
52. Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007;62(5) :407-14.
53. Fava GA. Do antidepressant and antianxiety drugs increase chro- nicity in affective disorders? Psychother Psychosom 1994;61(3- 4):125-31.
54. Shea MT, Leon AC, Mueller Tl, Solomon DA, Warshaw MG, Keller MB. Does major depression result in lasting personality change? Am J Psychiatry 1996; 153(11):1404-10.
55. Leistedt S, Dumont M, Coumans N, Lanquart JP, Jurysta F, Lin- kowski P. The modifications of the long-range temporal correlations of the sleep EEG due to major depressive episode disappear with the status of remission. Neuroscience 2007;148(3):782-93.
56. Fava M, Bouffides E, Pava JA, McCarthy MK, Steingard RJ, Ro- senbaum JF. Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother Psychosom 1994;62(3-4):160-7.
57. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996;153(7):945-7.
58. Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S. Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychological Med 1998;28(2): 475-80.
59. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, et al. Prevention of relapse in residual depression by cognitive therapy: A controlled trial. Arch Gen Psychiatry 1999;56(9):829-35.
60. Scott J, Teasdale JD, Paykel ES, Johnson AL, Abbott R, Hayhurst H, et al. Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. Br J Psychiatry 2000;177:440-6.
61. Teasdale JD, Scott J, Moore RG, Hayhurst H, Pope M, Paykel ES. How does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial. J Consult Clin Psychol 2001;69(3):347-57.
62. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349(9064):1498- 504.
63. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: A metaanalysis of data submitted to the Food and Drug Administration. PLoS Medicine 2008;5(2):e45.
64. Fava GA, Tomba E, Grandi S. The road to recovery from depression-don't drive today with yesterday's map. Psychother Psychosom 2007;76(5):260-5.
65. Moncrieff J, Cohen D. Do antidepressants cure or create abnormal brain states? PLoS Medicine. 2006;3(7):e240.
66. Kirsch I, Moncrieff J. Clinical trials and the response rate illusion. Contemporary Clinical Trials 2007;28(4):348-51.
67. Fava GA, Ruini C, Belaise C. The concept of recovery in major depression. Psychological Med 2007;37(3):307-17.
68. Ormel J, Oldehinkel T, Brilman E, Vanden Brink W. Outcome of depression and anxiety in primary care. A three-wave 3 1/2-year study of psychopathology and disability. Arch Gen Psychiatry 1993;50(10):759-66.